Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care therapies (investigator’s choice), resulting in an ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.

Get all latest & breaking news on Simplex Project. Watch videos, top stories and articles on Simplex Project at moneycontrol.com.

Get all latest & breaking news on Simplex Projects. Watch videos, top stories and articles on Simplex Projects at moneycontrol.com.

Full abstracts will be released on February 4, 2026, at 7:00 am CET/1:00 am EST and will be available via the conference website here .

NASCAR has announced another schedule change for the NASCAR Clash at Bowman Gray Stadium as winter weather continues to ...

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

After flying across the English Channel in his excellent Type XI monoplane, Louis Blériot tried and often failed to follow up ...

Herpes simplex virus (HSV) encephalitis, caused by HSV types 1 and 2, is the most common sporadic viral encephalitis worldwide, with an annual incidence of around 2·2–4·6 per million people.1 Before ...

WOBURN, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

How varicella zoster virus vaccination may provide protection remains a mystery ...